vs
Side-by-side financial comparison of AstroNova, Inc. (ALOT) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $39.2M, roughly 1.5× AstroNova, Inc.). AstroNova, Inc. runs the higher net margin — 1.0% vs -83.0%, a 83.9% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs -3.4%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 2.1%).
AstroNova, Inc. is a global technology firm designing, manufacturing and distributing specialty data visualization products, including high-performance label printers, test and measurement equipment, and aerospace-grade data recording systems, serving aerospace, manufacturing, retail and healthcare markets worldwide.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
ALOT vs RYTM — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $39.2M | $57.3M |
| Net Profit | $378.0K | $-47.5M |
| Gross Margin | 36.2% | 91.6% |
| Operating Margin | 3.3% | -82.2% |
| Net Margin | 1.0% | -83.0% |
| Revenue YoY | -3.4% | 36.9% |
| Net Profit YoY | 221.5% | -9.6% |
| EPS (diluted) | $0.05 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $39.2M | $57.3M | ||
| Q3 25 | $36.1M | $51.3M | ||
| Q2 25 | $37.7M | $48.5M | ||
| Q1 25 | — | $32.7M | ||
| Q4 24 | $40.4M | $41.8M | ||
| Q3 24 | $40.5M | $33.3M | ||
| Q2 24 | $33.0M | $29.1M | ||
| Q1 24 | $39.6M | $26.0M |
| Q4 25 | $378.0K | $-47.5M | ||
| Q3 25 | $-1.2M | $-52.9M | ||
| Q2 25 | $-376.0K | $-46.6M | ||
| Q1 25 | — | $-49.5M | ||
| Q4 24 | $240.0K | $-43.3M | ||
| Q3 24 | $-311.0K | $-43.6M | ||
| Q2 24 | $1.2M | $-32.3M | ||
| Q1 24 | $2.7M | $-141.4M |
| Q4 25 | 36.2% | 91.6% | ||
| Q3 25 | 32.2% | 89.3% | ||
| Q2 25 | 33.6% | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | 33.9% | 90.9% | ||
| Q3 24 | 35.3% | 88.5% | ||
| Q2 24 | 36.3% | 89.9% | ||
| Q1 24 | 31.9% | 89.2% |
| Q4 25 | 3.3% | -82.2% | ||
| Q3 25 | -2.0% | -102.6% | ||
| Q2 25 | 1.5% | -93.4% | ||
| Q1 25 | — | -143.7% | ||
| Q4 24 | 3.1% | -98.6% | ||
| Q3 24 | 2.6% | -132.0% | ||
| Q2 24 | 4.1% | -139.2% | ||
| Q1 24 | 9.9% | -538.7% |
| Q4 25 | 1.0% | -83.0% | ||
| Q3 25 | -3.4% | -103.1% | ||
| Q2 25 | -1.0% | -96.1% | ||
| Q1 25 | — | -151.4% | ||
| Q4 24 | 0.6% | -103.6% | ||
| Q3 24 | -0.8% | -131.2% | ||
| Q2 24 | 3.6% | -110.9% | ||
| Q1 24 | 6.8% | -544.4% |
| Q4 25 | $0.05 | $-0.73 | ||
| Q3 25 | $-0.16 | $-0.82 | ||
| Q2 25 | $-0.05 | $-0.75 | ||
| Q1 25 | — | $-0.81 | ||
| Q4 24 | $0.03 | $-0.71 | ||
| Q3 24 | $-0.04 | $-0.73 | ||
| Q2 24 | $0.15 | $-0.55 | ||
| Q1 24 | $0.37 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.6M | $388.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $76.9M | $139.1M |
| Total Assets | $140.8M | $480.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.6M | $388.9M | ||
| Q3 25 | $3.9M | $416.1M | ||
| Q2 25 | $5.4M | $291.0M | ||
| Q1 25 | — | $314.5M | ||
| Q4 24 | $4.4M | $320.6M | ||
| Q3 24 | $4.8M | $298.4M | ||
| Q2 24 | $4.0M | $319.1M | ||
| Q1 24 | $4.5M | $201.2M |
| Q4 25 | $76.9M | $139.1M | ||
| Q3 25 | $75.8M | $148.8M | ||
| Q2 25 | $76.6M | $-11.9M | ||
| Q1 25 | — | $18.9M | ||
| Q4 24 | $92.2M | $21.7M | ||
| Q3 24 | $91.8M | $11.2M | ||
| Q2 24 | $91.2M | $39.3M | ||
| Q1 24 | $90.3M | $61.6M |
| Q4 25 | $140.8M | $480.2M | ||
| Q3 25 | $143.1M | $506.9M | ||
| Q2 25 | $150.3M | $372.7M | ||
| Q1 25 | — | $386.7M | ||
| Q4 24 | $166.5M | $392.3M | ||
| Q3 24 | $169.0M | $363.6M | ||
| Q2 24 | $126.6M | $381.8M | ||
| Q1 24 | $133.3M | $258.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.4M | $-25.4M |
| Free Cash FlowOCF − Capex | $3.3M | — |
| FCF MarginFCF / Revenue | 8.5% | — |
| Capex IntensityCapex / Revenue | 0.2% | — |
| Cash ConversionOCF / Net Profit | 9.05× | — |
| TTM Free Cash FlowTrailing 4 quarters | $2.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.4M | $-25.4M | ||
| Q3 25 | $249.0K | $-26.6M | ||
| Q2 25 | $4.4M | $-23.3M | ||
| Q1 25 | — | $-40.4M | ||
| Q4 24 | $-4.7M | $-18.8M | ||
| Q3 24 | $162.0K | $-25.2M | ||
| Q2 24 | $6.9M | $-29.1M | ||
| Q1 24 | $6.5M | $-40.7M |
| Q4 25 | $3.3M | — | ||
| Q3 25 | $202.0K | — | ||
| Q2 25 | $4.3M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-5.0M | — | ||
| Q3 24 | $-176.0K | — | ||
| Q2 24 | $6.4M | — | ||
| Q1 24 | $6.0M | — |
| Q4 25 | 8.5% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | 11.5% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -12.4% | — | ||
| Q3 24 | -0.4% | — | ||
| Q2 24 | 19.5% | — | ||
| Q1 24 | 15.3% | — |
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 1.0% | — |
| Q4 25 | 9.05× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -19.76× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.85× | — | ||
| Q1 24 | 2.38× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALOT
| Public Utilities Inventory Supplies | $20.6M | 53% |
| Hardware Products | $12.7M | 32% |
| Service And Other | $5.9M | 15% |
RYTM
Segment breakdown not available.
